// App-Quantinova.ai

256 : Exploring PIM1 as a measurable therapeutic target in early rheumatoid arthritis

Researchers

Presenter

  • Nicola J Maney

Principal Investigators

  • Amy E Anderson

  • Nisha Nair

  • Ann Barton

  • John D Isaacs

  • Arthur G Pratt

Medical Centers

  • National Institute for Health Research Newcastle Biomedical Research Centre, Newcastle Upon Tyne Hospitals NHS Foundation Trust and Newcastle University, Newcastle Upon Tyne, UK

  • Arthritis Research UK Centre for Genetics and Genomics, Centre for Musculoskeletal Research, Institute of Inflammation and Repair and NIHR Manchester Musculoskeletal BRU, University of Manchester and Central Manchester NHS Foundation Trust, Manchester, UNITED KINGDOM

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • Cluster of Differentiation 2AP

  • Cluster of Differentiation 4

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved